TARGET follow-up study

Lancet. 2002 Dec;360(9350):2085-6; author reply 2086. doi: 10.1016/S0140-6736(02)11982-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Abciximab
  • Antibodies, Monoclonal / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Myocardial Infarction / drug therapy*
  • Patient Selection*
  • Reproducibility of Results
  • Tirofiban
  • Tyrosine / analogs & derivatives
  • Tyrosine / therapeutic use*
  • United States

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Tyrosine
  • Tirofiban
  • Abciximab